U.S. Markets open in 1 hr 3 mins
  • S&P Futures

    4,143.50
    +25.50 (+0.62%)
     
  • Dow Futures

    33,804.00
    +180.00 (+0.54%)
     
  • Nasdaq Futures

    13,921.50
    +122.75 (+0.89%)
     
  • Russell 2000 Futures

    2,269.80
    +24.80 (+1.10%)
     
  • Crude Oil

    62.82
    -0.33 (-0.52%)
     
  • Gold

    1,751.40
    +15.10 (+0.87%)
     
  • Silver

    25.69
    +0.17 (+0.67%)
     
  • EUR/USD

    1.1973
    +0.0019 (+0.1556%)
     
  • 10-Yr Bond

    1.6380
    0.0000 (0.00%)
     
  • Vix

    16.73
    +0.08 (+0.48%)
     
  • GBP/USD

    1.3793
    +0.0040 (+0.2938%)
     
  • USD/JPY

    108.7900
    -0.2580 (-0.2366%)
     
  • BTC-USD

    62,689.91
    -1,792.27 (-2.78%)
     
  • CMC Crypto 200

    1,369.79
    -5.99 (-0.44%)
     
  • FTSE 100

    6,971.04
    +31.46 (+0.45%)
     
  • Nikkei 225

    29,642.69
    +21.70 (+0.07%)
     

Johnson & Johnson Pulls Talc-Based Baby Powder From US, Canada As Cancer Claims Kill Demand

  • Oops!
    Something went wrong.
    Please try again later.
Neer Varshney
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Johnson & Johnson (NYSE: JNJ) on Tuesday announced it is discontinuing its talc-based baby powder line in the United States and Canada.

What Happened

The New Jersey-based company said the decision came as part of its portfolio assessment related to novel coronavirus (COVID-19), with another 99 products also being permanently discontinued.

It noted that the demand for its talc-based baby powder reduced in the face of thousands of lawsuits claiming the product can cause cancer.

"Demand for talc-based Johnson's Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising," Johnson & Johnson said in a statement.

According to the company, the talc-based powder contributed to about 0.5% of its total U.S. Consumer Health business.

It said its cornstarch-based baby powder would continue to be available in the two countries, and the existing inventory of the talc-based powder will also be cleared.

Why It Matters

The talc-based powder will remain available in other countries beside the U.S. and Canada, where demand for the product remains high, the statement read.

Johnson & Johnson recalled a batch of the baby powder in October last year after the Food and Drug Administration found traces of Asbestos, a known carcinogen, in samples from a bottle sold through an online retailer.

Later in December, the company said third-party scientific tests found no trace of Asbestos in the baby powder.

Johnson & Johnson noted it would continue to "vigorously defend" the product in court, even if it has pulled it from North American markets.

Price Action

The company's shares closed 1% lower at $149.02 on Tuesday. The shares traded another 0.3% lower at $148.51.

Image Credit: Wikimedia.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.